JMKX000623
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JMKX000623, covering 2024-04-25 to 2024-04-25. Get the full timeline:
Most recent: Clinical Trial Update: A DDI Study of JMKX000623 and Metformin Hydrochloride [Phase 1]